Litcius/Paper detail

Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma

Zeynep Büşra Zengin, Alex Chehrazi‐Raffle, Nicholas Salgia, Ramya Muddasani, Sana Ali, Luís Meza, Sumanta K. Pal

2021Urologic Oncology Seminars and Original Investigations27 citationsDOI

Topics & Concepts

Fibroblast growth factor receptorFibroblast growth factor receptor 1MedicineTargeted therapyCancer researchImmune checkpointImmunotherapyCancerOncologyFibroblast growth factorImmunologyInternal medicineReceptorBladder and Urothelial Cancer TreatmentsFibroblast Growth Factor ResearchUrinary and Genital Oncology Studies
Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma | Litcius